Aopwiki

SNAPSHOT

Created at: 2019-01-04 08:29

AOP ID and Title:


AOP 29: Estrogen receptor agonism leading to reproductive dysfunction
Short Title: Estrogen receptor agonism leading to reproductive dysfunction

Authors


  • Professor Tom Hutchinson, School of Biological Sciences, Plymouth, UK [tom.hutchinson{at}plymouth.ac.uk]
  • Dan Villeneuve, US EPA Mid-Continent Ecology Division, Duluth, MN. [villeneuve.dan{at}epa.gov]

Status

Author status OECD status OECD project SAAOP status
Under development: Not open for comment. Do not cite 1.29 Under Development

Abstract


This AOP describes the linkages between agonism of the estrogen receptor (ER) and population relevant impacts on reproductive function in a range of oviparous vertebrates including amphibia, birds and fish. The information in this AOP for ER agonism does not apply to mammalian species and also not to invertebrates.



Amphibians are sensitive to ER agonists during the transformation from larval tadpole to juvenile frog as these include critical periods of metamorphic development and sex differentiation that may be particularly sensitive to endocrine disruption. Larvae exposed to ER agonists during mid-metamorphosis show developmental effects, a subsequent strong female-biased sex ratio which suggests that transient early life-stage exposure to ER agonists can produce effects on the reproductive organs that persist into the beginning of adult life-stages. Birds are also known to be vulnerable to ER agonists causing disruption of estrogen-regulated functions such as sexual differentiation and sexual behaviour. Model species such as the Japanese quail have been widely used as a model for studying various long-term effects after embryonic exposure to ER agonists. In terms of teleost fish, exposure to ER agonists leads to a suite of adverse outcomes depending upon whether exposures occur during or beyond the larval, juvenile and adult life-stages. For example, aquatic exposure to potent ER agonists during the larval and juvenile life-stages may leads to gonadal and renal pathology and skewed-sex ratios in adult fish (potentially 100% females). Larval, juvenile and adult male fish exposed to the same ER agonists display abnormal plasma or whole body levels of vitellogenin (VTG). Cumulative fecundity in adult populations is also adversely affected by ER agonists and this is an important endpoint in the OECD Test Guideline 229 Fish Short Term Reproduction Assay. In summary, this AOP has utility in supporting the application of test methods for detecting ER agonists, or in silico predictions of the ability of chemicals to act as ER agonists and cause impaired sexual development and reproductive dysfunction.



Summary of the AOP

Events

Molecular Initiating Events (MIE), Key Events (KE), Adverse Outcomes (AO)

Sequence Type Event ID Title Short name
1 MIE 111 Agonism, Estrogen receptor Agonism, Estrogen receptor
2 KE 78 Reduction, Cumulative fecundity and spawning Reduction, Cumulative fecundity and spawning
3 KE 220 Increase, Plasma vitellogenin concentrations Increase, Plasma vitellogenin concentrations
4 KE 307 Increase, Vitellogenin synthesis in liver Increase, Vitellogenin synthesis in liver
5 KE 252 Increase, Renal pathology due to VTG deposition Increase, Renal pathology due to VTG deposition
6 AO 360 Decrease, Population trajectory Decrease, Population trajectory
7 AO 363 Altered, Reproductive behaviour Altered, Reproductive behaviour
8 AO 339 Altered, Larval development Altered, Larval development
9 AO 364 Impaired development of, Reproductive organs Impaired development of, Reproductive organs

Key Event Relationships

Upstream Event Relationship Type Downstream Event Evidence Quantitative Understanding
Agonism, Estrogen receptor adjacent Impaired development of, Reproductive organs High
Increase, Renal pathology due to VTG deposition adjacent Altered, Larval development High
Agonism, Estrogen receptor adjacent Increase, Vitellogenin synthesis in liver High
Increase, Plasma vitellogenin concentrations adjacent Increase, Renal pathology due to VTG deposition High
Agonism, Estrogen receptor adjacent Altered, Reproductive behaviour High
Increase, Vitellogenin synthesis in liver adjacent Increase, Plasma vitellogenin concentrations High

Overall Assessment of the AOP

In terms of the criteria associated with Key Events in this AOP, the following observations have been made as shown in parentheses []:

1. concordance of dose-response relationships?; [There is strong dose-response relationship concordance over a wide range of experimental studies using ER agonists in well-defined animals models, including amphibians, birds and fish];

2. temporal concordance among the key events and adverse effect?; [There is strong temporal concordance from partial and full life-cycle studies using ER agonists in well-defined animals models];

3. strength, consistency, and specificity of association of adverse effect and initiating event?; [In fish, there is a strong and consistent association between ER agonist exposure, disruption of sexual development and reproductive dysfunction. The same is true for amphibians and birds although the published studies are less numerous.];

4. biological plausibility, coherence, and consistency of the experimental evidence?; [For the oviparous species frequently studied to date, there is a high level of biological plausibility, coherence, and consistency across the published experimental evidence];

5. alternative mechanisms that logically present themselves and the extent to which they may distract from the postulated AOP?; [Other mechanisms of relevance to estrogen-mediated sexual development include the disruption of the steroidogenic pathways (eg see the AOP for aromatase inhibition in fish) and this alterative AOP should be considered alongside ER agonism in the context of elevated plasma VTG levels, disrupted sexual development of reproductive dysfunction. The possibility of other AOPs arisign should be kept in mind through critical analysis of the updated pree-reviewed literature];

6. uncertainties, inconsistencies and data gaps?; [An important aspect of uncertainty is quantifying the degree to which disrupted sexual development leads to a population-relevant impact via reproductive dysfunction. Experimental and validated population modelling is a key need to address this data gap and uncertainty. In the author's view, there are no major scientific inconsistencies with regard to the ER agonism AOP and associated Key Events].


Domain of Applicability

Life Stage Applicability
Life Stage Evidence
Juvenile High
Embryo High
Taxonomic Applicability
Term Scientific Term Evidence Links
fathead minnow Pimephales promelas High NCBI
Japanese quail Coturnix japonica High NCBI
northern leopard frog Rana pipiens High NCBI
medaka Oryzias latipes High NCBI
zebrafish Danio rerio High NCBI
Sex Applicability
Sex Evidence
Male High

Life Stage Applicability, Taxonomic Applicability, Sex Applicability
In terms of the taxonomic domains of applicability, exposure to ER agonists is capable of disrupting sexual development and causing reproductive dysfunction in oviparous species suchas amphibians, birds and fish (see examples of peer-revised literature cited below).

References



Dang, Z., Traas, T., Vermeire, T. (2011) Evaluation of the fish short term reproduction assay for detecting endocrine disrupters. Chemosphere 85: 1592-1603

Halldin, K., Axelsson, J., Brunström, B., (2005) Effects of endocrine modulators on sexual differentiation and reproductive function in male Japanese quail. Brain Research Bulletin 65: 211-218

Hogan, N.S., Duarte, P., Wade, M.G., Lean, D.R.S., Trudeau, V.L. (2008) Estrogenic exposure affects metamorphosis and alters sex ratios in the northern leopard frog (Rana pipiens): Identifying critically vulnerable periods of development. General and Comparative Endocrinology 156: 515-523

Hutchinson T.H. (2002) Impacts of endocrine disrupters on fish development: opportunities for adapting OECD Test Guideline 210. Environmental Sciences 9: 439-450

Länge R., Hutchinson T.H., Croudace C.P., Siegmund F., Schweinfurth H., Hampe P., Panter G.H., Sumpter J.P. (2001) Effects of the synthetic oestrogen 17-ethinylestradiol over the life-cycle of the fathead minnow. Environmental Toxicology and Chemistry 20: 1216–1227

Leino, R.L., Jensen,K.M., Ankley, G.T. (2005) Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow (Pimephales promelas). Environmental Toxicology and Pharmacology 19: 85-98

Ottinger, M.N., Carro, T., Bohannon, M., Baltos,L., Marcell, A.M., McKernan, M., Dean, K.M., Lavoie, E., Abdelnabi, M. (2013) Assessing effects of environmental chemicals on neuroendocrine systems: Potential mechanisms and functional outcomes. General and Comparative Endocrinology 190: 194-202


Appendix 1

List of MIEs in this AOP

Event: 111: Agonism, Estrogen receptor

Short Name: Agonism, Estrogen receptor

Key Event Component

Process Object Action
estrogen receptor activity estrogen receptor increased

Biological Context

Level of Biological Organization
Molecular

Cell term

Cell term
hepatocyte

List of Key Events in the AOP

Event: 78: Reduction, Cumulative fecundity and spawning

Short Name: Reduction, Cumulative fecundity and spawning

Key Event Component

Process Object Action
egg quantity decreased

Stressors

Name
Tris(1,3-dichloropropyl)phosphate - TDCPP

Biological Context

Level of Biological Organization
Individual

Evidence for Perturbation by Stressor



Tris(1,3-dichloropropyl)phosphate - TDCPP

Reduction of cumulative fecundity and spawning following exposure to low levels of TDCIPP (15, 46 and 90 nM) has been reported in 3 different zebrafish studies (Liu et al., 2013; Wang et al., 2015a; Zhu et al., 2015).


Domain of Applicability


Taxonomic Applicability
Term Scientific Term Evidence Links
fathead minnow Pimephales promelas High NCBI
Fundulus heteroclitus Fundulus heteroclitus High NCBI
Oryzias latipes Oryzias latipes High NCBI
Life Stage Applicability
Life Stage Evidence
Adult, reproductively mature High
Sex Applicability
Sex Evidence
Female High

Cumulative fecundity and spawning can, in theory, be evaluated for any egg laying animal.


Key Event Description

Spawning refers to the release of eggs. Cumulative fecundity refers to the total number of eggs deposited by a female, or group of females over a specified period of time.


How it is Measured or Detected

In laboratory-based reproduction assays (e.g., OECD Test No. 229; OECD Test No. 240), spawning and cumulative fecundity can be directly measured through daily observation of egg deposition and egg counts.

In some cases, fecundity may be estimated based on gonado-somatic index (OECD 2008).


Regulatory Significance of the AO

Cumulative fecundity is the most apical endpoint considered in the OECD 229 Fish Short Term Reproduction Assay. The OECD 229 assay serves as screening assay for endocrine disruption and associated reproductive impairment (OECD 2012). Fecundity is also an important apical endpoint in the Medaka Extended One Generation Reproduction Test (MEOGRT; OECD Test Guideline 240; OECD 2015).

A variety of fish life cycle tests also include cumulative fecundity as an endpoint (OECD 2008).

 


References

  • OECD 2008. Series on testing and assessment, Number 95. Detailed Review Paper on Fish Life-cycle Tests. OECD Publishing, Paris. ENV/JM/MONO(2008)22.
  • OECD (2015), Test No. 240: Medaka Extended One Generation Reproduction Test (MEOGRT), OECD Publishing, Paris.
    DOI: http://dx.doi.org/10.1787/9789264242258-en
  • OECD. 2012a. Test no. 229: Fish short term reproduction assay. Paris, France:Organization for Economic Cooperation and Development.

Event: 220: Increase, Plasma vitellogenin concentrations

Short Name: Increase, Plasma vitellogenin concentrations

Key Event Component

Process Object Action
vitellogenins increased

Biological Context

Level of Biological Organization
Organ

Organ term

Organ term
blood plasma

Event: 307: Increase, Vitellogenin synthesis in liver

Short Name: Increase, Vitellogenin synthesis in liver

Key Event Component

Process Object Action
gene expression vitellogenins increased

AOPs Including This Key Event


Biological Context

Level of Biological Organization
Tissue

Organ term

Organ term
liver

Event: 252: Increase, Renal pathology due to VTG deposition

Short Name: Increase, Renal pathology due to VTG deposition

Key Event Component

Process Object Action
Kidney Diseases increased

AOPs Including This Key Event


Biological Context

Level of Biological Organization
Organ

Organ term

Organ term
kidney

List of Adverse Outcomes in this AOP

Event: 360: Decrease, Population trajectory

Short Name: Decrease, Population trajectory

Key Event Component

Process Object Action
population growth rate decreased

AOPs Including This Key Event

AOP ID and Name Event Type
Aop:23 - Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish) AdverseOutcome
Aop:25 - Aromatase inhibition leading to reproductive dysfunction AdverseOutcome
Aop:29 - Estrogen receptor agonism leading to reproductive dysfunction AdverseOutcome
Aop:30 - Estrogen receptor antagonism leading to reproductive dysfunction AdverseOutcome
Aop:100 - Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of female spawning behavior AdverseOutcome
Aop:122 - Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation AdverseOutcome
Aop:123 - Unknown MIE leading to reproductive dysfunction via increased HIF-1alpha transcription AdverseOutcome
Aop:155 - Deiodinase 2 inhibition leading to reduced young of year survival via posterior swim bladder inflation AdverseOutcome
Aop:156 - Deiodinase 2 inhibition leading to reduced young of year survival via anterior swim bladder inflation AdverseOutcome
Aop:157 - Deiodinase 1 inhibition leading to reduced young of year survival via posterior swim bladder inflation AdverseOutcome
Aop:158 - Deiodinase 1 inhibition leading to reduced young of year survival via anterior swim bladder inflation AdverseOutcome
Aop:159 - Thyroperoxidase inhibition leading to reduced young of year survival via anterior swim bladder inflation AdverseOutcome
Aop:101 - Cyclooxygenase inhibition leading to reproductive dysfunction via inhibition of pheromone release AdverseOutcome
Aop:102 - Cyclooxygenase inhibition leading to reproductive dysfunction via interference with meiotic prophase I /metaphase I transition AdverseOutcome
Aop:63 - Cyclooxygenase inhibition leading to reproductive dysfunction AdverseOutcome
Aop:103 - Cyclooxygenase inhibition leading to reproductive dysfunction via interference with spindle assembly checkpoint AdverseOutcome

Biological Context

Level of Biological Organization
Population

Domain of Applicability


Taxonomic Applicability
Term Scientific Term Evidence Links
all species all species NCBI
Life Stage Applicability
Life Stage Evidence
All life stages Not Specified
Sex Applicability
Sex Evidence
Unspecific Not Specified

Consideration of population size and changes in population size over time is potentially relevant to all living organisms.


Key Event Description

Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is an accepted regulatory goal upon which risk assessments and risk management decisions are based.


How it is Measured or Detected

Population trajectories, either hypothetical or site specific, can be estimated via population modeling based on measurements of vital rates or reasonable surrogates measured in laboratory studies. As an example, Miller and Ankley 2004 used measures of cumulative fecundity from laboratory studies with repeat spawning fish species to predict population-level consequences of continuous exposure.


Regulatory Significance of the AO

Maintenance of sustainable fish and wildlife populations (i.e., adequate to ensure long-term delivery of valued ecosystem services) is a widely accepted regulatory goal upon which risk assessments and risk management decisions are based.


References

  • Miller DH, Ankley GT. 2004. Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17ß-trenbolone as a case study. Ecotoxicology and Environmental Safety 59: 1-9.

Event: 363: Altered, Reproductive behaviour

Short Name: Altered, Reproductive behaviour

Key Event Component

Process Object Action
reproductive behavior abnormal

AOPs Including This Key Event


Biological Context

Level of Biological Organization
Individual

Event: 339: Altered, Larval development

Short Name: Altered, Larval development

Key Event Component

Process Object Action
larval development abnormal

AOPs Including This Key Event


Biological Context

Level of Biological Organization
Individual

Event: 364: Impaired development of, Reproductive organs

Short Name: Impaired development of, Reproductive organs

Key Event Component

Process Object Action
developmental process reproductive organ abnormal

AOPs Including This Key Event


Biological Context

Level of Biological Organization
Individual

Appendix 2

List of Key Event Relationships in the AOP